Ligand Pharmaceuticals (LGND) News Today $186.98 +1.73 (+0.93%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$186.99 +0.01 (+0.01%) As of 10/24/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LGND Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Acuitas Investments LLC Has $2.26 Million Stock Holdings in Ligand Pharmaceuticals Incorporated $LGNDOctober 24 at 7:18 AM | marketbeat.comLigand to Report Third Quarter 2025 Financial Results on November 6, 2025October 23 at 7:00 AM | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Hits New 12-Month High - Still a Buy?October 22 at 1:32 PM | marketbeat.comStephens Investment Management Group LLC Sells 2,409 Shares of Ligand Pharmaceuticals Incorporated $LGNDOctober 22 at 9:11 AM | marketbeat.comAllspring Global Investments Holdings LLC Sells 20,374 Shares of Ligand Pharmaceuticals Incorporated $LGNDOctober 20, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Hits New 12-Month High - Here's WhyOctober 17, 2025 | marketbeat.comTweedy Browne Co LLC Takes Position in Ligand Pharmaceuticals Incorporated $LGNDOctober 17, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Position Decreased by Blair William & Co. ILOctober 17, 2025 | marketbeat.comLigand to Host Investor Day on December 9, 2025October 16, 2025 | globenewswire.comEquitable Trust Co. Acquires 1,710 Shares of Ligand Pharmaceuticals Incorporated $LGNDOctober 16, 2025 | marketbeat.comAberdeen Group plc Has $26.06 Million Holdings in Ligand Pharmaceuticals Incorporated $LGNDOctober 14, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of "Moderate Buy" by AnalystsOctober 13, 2025 | marketbeat.comVillere ST Denis J & Co. LLC Has $32.64 Million Position in Ligand Pharmaceuticals Incorporated $LGNDOctober 11, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Earns Sell (D+) Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comLigand partner SQ Innovation receives approval from FDA for Lasix ONYUOctober 9, 2025 | msn.comLigand Pharmaceuticals Announces FDA Approval of Lasix ONYU, Innovative Subcutaneous Delivery Device for Edema Treatment in Heart Failure PatientsOctober 9, 2025 | quiverquant.comQLigand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure PatientsOctober 9, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 1-Year High - Here's What HappenedOctober 6, 2025 | marketbeat.comJohn Kozarich Sells 467 Shares of Ligand Pharmaceuticals (NASDAQ:LGND) StockOctober 4, 2025 | insidertrades.comLigand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 SharesOctober 3, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Purchased by Chicago Capital LLCSeptember 30, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 12-Month High - What's Next?September 29, 2025 | marketbeat.comCongress Asset Management Co. Raises Stake in Ligand Pharmaceuticals Incorporated $LGNDSeptember 26, 2025 | marketbeat.comJason Aryeh Sells 10,000 Shares of Ligand Pharmaceuticals (NASDAQ:LGND) StockSeptember 25, 2025 | insidertrades.comArecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292September 25, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Director Sells $1,708,100.00 in StockSeptember 24, 2025 | marketbeat.comStrs Ohio Invests $789,000 in Ligand Pharmaceuticals Incorporated $LGNDSeptember 20, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 12-Month High - Here's WhySeptember 19, 2025 | marketbeat.comContravisory Investment Management Inc. Takes Position in Ligand Pharmaceuticals Incorporated $LGNDSeptember 19, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of "Buy" by AnalystsSeptember 18, 2025 | marketbeat.comLigand Pharma Amends Credit Agreement for StabilitySeptember 16, 2025 | tipranks.comRhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGNDSeptember 15, 2025 | marketbeat.comEllsworth Advisors LLC Makes New Investment in Ligand Pharmaceuticals Incorporated $LGNDSeptember 13, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Large Growth in Short InterestSeptember 11, 2025 | marketbeat.comBaird Financial Group Inc. Reduces Stock Position in Ligand Pharmaceuticals Incorporated $LGNDSeptember 10, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Invests $16.53 Million in Ligand Pharmaceuticals Incorporated $LGNDSeptember 9, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by Clark Capital Management Group Inc.September 7, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $190.00 at OppenheimerSeptember 5, 2025 | marketbeat.comInsider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 467 Shares of StockSeptember 5, 2025 | insidertrades.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High After Analyst UpgradeSeptember 5, 2025 | marketbeat.comBenchmark Forecasts Strong Price Appreciation for Ligand Pharmaceuticals (NASDAQ:LGND) StockSeptember 4, 2025 | marketbeat.comWhat Analysts Are Saying About Ligand Pharmaceuticals StockSeptember 3, 2025 | benzinga.comLigand Pharmaceuticals Incorporated $LGND Stake Reduced by Ashford Capital Management Inc.September 1, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Acquired by Northern Trust CorpSeptember 1, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Purchased by American Century Companies Inc.September 1, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst UpgradeAugust 31, 2025 | marketbeat.comNuveen LLC Buys New Stake in Ligand Pharmaceuticals Incorporated $LGNDAugust 29, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Buy" from BrokeragesAugust 26, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by CW Advisors LLCAugust 24, 2025 | marketbeat.comInvesco Ltd. Purchases 8,473 Shares of Ligand Pharmaceuticals Incorporated $LGNDAugust 23, 2025 | marketbeat.com Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LGND Media Mentions By Week LGND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼1.160.93▲Average Medical News Sentiment LGND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼66▲LGND Articles Average Week Get the Latest News and Ratings for LGND and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ligand Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADMA News Today ANIP News Today NBIX News Today EXAS News Today IONS News Today EXEL News Today BMRN News Today MDGL News Today RGEN News Today HALO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGND Stock Alerts